According to the latest reports, the most eagerly awaited Google (GOOGL) Android offering of the year, the Red Hydrogen One, will not be hitting the shelves until early November. The smartphone, which is supposed to be the world’s first holographic phone, is apparently getting delayed due to a manufacturing tweak that required the Federal Communications Commission’s approval.
The model is now set to hit the shelves of carriers AT&T (T) and Verizon (VZ) on November 2.
Beta testers, however, will get their hands on a limited number of developer’s prerelease model of Red Hydrogen One, called Houdini, from August 31 through September 11 this year. Also, those who preordered the smartphone will get it delivered by October 9.
Film camera brand Red came out with the holographic phone with 4-View technology, which is not available on any other phones right now. For the time being, the company will ship the aluminum models only in black and gray, while the titanium-model could reach the market by next year. The phone will cost you $1,295.
The Hydrogen One comes with 5.7-inch display with QHD resolution, 2D, 3D, 4-View holographic mode and Qualcomm’s (QCOM) Snapdragon 835 chip (similar to Samsung Galaxy S8 and Google Pixel 2).
Apart from that, it will feature USB Type-C connectivity, 4,500 mAh battery as well as the dual rear-view camera.
Apple (AAPL) already holds a holographic screens patent and will be keenly watching the performance of Hydrogen One. The iPhone maker will likely use this as a prototype and will work on any negative aspects that might crop out of this model.
This year, Apple is set to launch three new iPhone models – an update to the iPhone X, a plus-size variant, and a low-tag LCD model. The updates to iPhone X and a 6.5-inch variant, dubbed iPhone X Plus, are expected to have OLED screens, while the third device will probably come with 6.1-inch LCD display.
Related: All eyes on the next Apple iPhone, but delay on the cards
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on